Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design.
Hendrix, Craig W.
; 155(3): 515-8, 2013 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-24243011
Strategies for an HIV cure: progress and challenges.
Kick and kill for HIV latency.
Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.
An integrated overview of HIV-1 latency.
A New Era of HIV Risk: It's Not What You Know, It's Who You Know (and How Infectious).
Traitements antirétroviraux : vers un allègement ?
PrEP Stigma: Implicit and Explicit Drivers of Disparity.
Optimizing antiretroviral regimens in chronic kidney disease.
Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection.
Scaling up pre-exposure prophylaxis in sub-Saharan Africa.